Ozempic was approved for type 2 diabetes in 2017, but its origins at Novo Nordisk stretch back nearly a decade earlier
Brittany Johnson, PhD, RDN, lead author on the GNC studies, noted that although GLP-1 drugs deliver significant weight loss, long-term success depends on sustainable lifestyle support
Its during this adaptation period that many people start noticing the positive effects of semaglutide, such as reduced appetite and easier portion control
We conducted a subgroup analysis based on age to assess the proportional imbalance of AEs related to suicide/self-injury for GLP-1RA within different age groups
But if I see someone who's lived with obesity for a long period of time, like years as we said, years living with obesity I'm going to pay very close attention to them about their disease risk